News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Staff June 25, 2022 Iframe sync Post navigation Previous: Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next: Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program More Stories Brain Cancer News Pharmaceutical Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure Staff December 26, 2025 News Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026 Staff December 25, 2025 News Pharmaceutical XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Staff December 25, 2025
